comparemela.com
  1. Home
  2. Live Updates
  3. Cardior - Breaking News

Latest Breaking News On - Cardior - Page 1 : comparemela.com

Cardior Pharmaceuticals: Cardior Welcomes Dr Orly Vardeny as Permanent Guest to the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins

United statesRussell greigClaudia ulbrichKostenloser wertpapierhandelEva mulderClaudia ulbrich evaUniversity of minnesota medical schoolUniversity of minnesotaCardior pharmaceuticals gmbTrophic communicationsCardior pharmaceuticalsOrly vardenyMinnesota medical schoolAssociate editorHeart failureAmerican college

Cardior Appoints Axel-Sven Malkomes as Chief Financial Officer

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Axel-Sven Malkomes

Kellogg schoolUnited statesHong kongUnited kingdomRussell greigClaudia ulbrichDonaldson lufkin jenretteKostenloser wertpapierhandelEva mulderAxel sven malkomesClaudia ulbrich evaUniversity of science technology in hong kongCredit suisseTrophic communicationsDeutsche bankLehman brothers

Cardior Pharmaceuticals: Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit Used in Ongoing HF-REVERT Phase 2 Clinical Study

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the CE marking of its PCR kit which

Kostenloser wertpapierhandelThomas thumEva mulderClaudia ulbrich evaCardior pharmaceuticals gmbTrophic communicationsCardior pharmaceuticalsEuropean heart journalinClaudia ulbrich eva straPharmaceuticals gmbh

Cardior Pharmaceuticals: Cardior Appoints Dr Russell Greig as Independent Chairman of the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the appointment of Dr. Russell Greig

United kingdomRussell greigClaudia ulbrichKostenloser wertpapierhandelClaudia ulbrich barbara gaertner rupprechtMarkus hosangRussellg greigCharlotte spitzCardior pharmaceuticals gmbUniversity of manchesterTrophic communicationsCardior pharmaceuticalsGlaxosmithkline pharmaceuticals internationalGeneral partnerManaging directorVice chairman

Cardior Pharmaceuticals: Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the expansion of its Scientific Advisory

United kingdomCity ofUnited statesDavid crandallJohann bauersachsClaudia ulbrich barbara gaertner rupprechtPerry elliottBarry tichoCharlotte spitzGerasimos filippatosRahul agrawalKostenloser wertpapierhandelCommittee on clinical cardiovascular medicineUniversity college londonCommittee on acute heart failureUniversity of freiburg

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.